Investigator

Marta Hałas-Wiśniewska

Adjunkt · Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy, Department of Histology and Embryology

Research Interests

MHMarta Hałas-Wiśni…
Papers(1)
From Adhesion to Inva…
Collaborators(2)
Wioletta ArendtMagdalena Izdebska
Institutions(1)
Collegium Medicum In …

Papers

From Adhesion to Invasion: Integrins, Focal Adhesion Signaling, and Actin Binding Proteins in Cervical Cancer Progression—A Scoping Review

Background: Cervical cancer (CC) is one of the most common malignancies in women worldwide. Its progression involves a cascade of processes, including proliferation, migration, invasion, and metastasis. Each stage is regulated by specific signaling pathways. Objective: This scoping review aimed to map current evidence on the role of cell adhesion-related molecules, including integrins, focal adhesion (FA) proteins, and actin-binding proteins (ABPs), in CC progression. These protein groups act in a coordinated manner—integrins perceive and transmit extracellular matrix (ECM) signals, FA proteins mediate intracellular signaling, and ABPs reorganize the cytoskeleton, ensuring the continuity of adhesion and motility processes. Methods: A structured literature search was conducted for studies published between 2015 and 2025. Eligible articles described the role of adhesion-related proteins in migration, invasion, or EMT in CC. Data were synthesized thematically according to protein families. Results: The evidence highlights integrins, FA/FAK, and ABPs as interconnected regulators coordinating ECM signaling and cytoskeletal remodeling during CC progression. Their dysregulation is associated with enhanced migration, EMT induction, angiogenesis, and therapy resistance. Conclusions: This review provides a unique, integrated perspective linking adhesion molecules with invasion mechanisms in CC progression, providing new insights into their interplay. Understanding the interaction between these proteins is therefore a crucial step in the treatment of CC and may facilitate the discovery of biomarkers and support the development of targeted therapies.

24Works
1Papers
2Collaborators
Uterine Cervical NeoplasmsDisease ProgressionNeoplasm InvasivenessApoptosisBreast NeoplasmsPrognosisTumor Cells, Cultured

Positions

2020–

Adjunkt

Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy · Department of Histology and Embryology

2019–

Assistant

Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy · Department of Histology and Embyology

2012–

Senior technician

Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy · Department of Histology and Embryology

Education

2020

PhD

Collegium Medicum in Bydgoszcz

2012

MSc

Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy

2010

BSc

Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum im Ludwika Rydygiera w Bydgoszczy

Country

PL